Keefe Bruyette lowered the firm’s price target on Bill (BILL) to $46 from $54 and keeps a Market Perform rating on the shares post the fiscal Q4 report. The firm cut estimates citing the company’s weaker than expected outlook. The outlook reflects continued macro uncertainty and it is tough to be optimistic Bill “given the uncertainty that has persisted for quite some time,” the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BILL: